| Forecasting COVID-19 confirmed cases, deaths and recoveries: Revisiting established time series modeling through novel applications for the USA and Italy E Gecili, A Ziady, RD Szczesniak PloS one 16 (1), e0244173, 2021 | 57 | 2021 |
| Influences of environmental exposures on individuals living with cystic fibrosis R Szczesniak, JL Rice, C Brokamp, P Ryan, T Pestian, Y Ni, ... Expert review of respiratory medicine 14 (7), 737-748, 2020 | 27 | 2020 |
| Tissue-localized immune responses in people with cystic fibrosis and respiratory nontuberculous mycobacteria infection D Hayes Jr, RK Shukla, Y Cheng, E Gecili, MR Merling, RD Szczesniak, ... JCI insight 7 (12), 2022 | 7 | 2022 |
| Functional data analysis and prediction tools for continuous glucose-monitoring studies E Gecili, R Huang, JC Khoury, E King, M Altaye, K Bowers, ... Journal of Clinical and Translational Science, 1-10, 2020 | 7 | 2020 |
| Lung function decline in cystic fibrosis: impact of data availability and modeling strategies on clinical interpretations R Szczesniak, ER Andrinopoulou, W Su, PM Afonso, PR Burgel, ... Annals of the American Thoracic Society 20 (7), 958-968, 2023 | 4 | 2023 |
| Bayesian regularization for a nonstationary Gaussian linear mixed effects model E Gecili, S Sivaganesan, O Asar, JP Clancy, A Ziady, RD Szczesniak Statistics in Medicine, 2022 | 4 | 2022 |
| Sweat metabolomics before and after intravenous antibiotics for pulmonary exacerbation in people with cystic fibrosis FW Woodley, E Gecili, RD Szczesniak, CL Shrestha, CJ Nemastil, ... Respiratory medicine 191, 106687, 2022 | 4 | 2022 |
| An empirical comparison of segmented and stochastic linear mixed effects models to estimate rapid disease progression in longitudinal biomarker studies W Su, E Gecili, X Wang, RD Szczesniak Statistics in biopharmaceutical research 13 (3), 270-279, 2021 | 4 | 2021 |
| Seasonal variation of lung function in cystic fibrosis: longitudinal modeling to compare a Midwest US cohort to international populations E Gecili, C Brokamp, A Palipana, R Huang, ER Andrinopoulou, T Pestian, ... Science of The Total Environment 776, 145905, 2021 | 3 | 2021 |
| Cystic fibrosis point of personalized detection (cfpopd): An interactive web application C Wolfe, T Pestian, E Gecili, W Su, RH Keogh, JP Pestian, M Seid, ... JMIR medical informatics 8 (12), e23530, 2020 | 3 | 2020 |
| Feedback at the Point of Care to Decrease Medication Alert Rates in an Electronic Health Record PJ Van Camp, ES Kirkendall, PA Hagedorn, T Minich, M Kouril, ... Pediatric Emergency Care 36 (7), e417-e422, 2020 | 2 | 2020 |
| Predicting Individualized Lung Disease Progression in Treatment-Naive Patients With Lymphangioleiomyomatosis AK Palipana, E Gecili, S Song, SR Johnson, RD Szczesniak, N Gupta Chest 163 (6), 1458-1470, 2023 | 1 | 2023 |
| Built environment factors predictive of early rapid lung function decline in cystic fibrosis E Gecili, C Brokamp, E Rasnick, PM Afonso, ER Andrinopoulou, ... Pediatric pulmonology 58 (5), 1501-1513, 2023 | 1 | 2023 |
| BODY COMPOSITION AND FUNCTIONAL CORRELATES OF CF YOUTH EXPERIENCING PULMONARY EXACERBATION AND RECOVERY T Boat, E Hente, W Hardie, R Szczesniak, E Gecili, G Zhou, J Taylor, ... Pediatric Pulmonology, 2022 | 1 | 2022 |
| Seasonality, mediation and comparison (SMAC) methods to identify influences on lung function decline E Gecili, A Palipana, C Brokamp, R Huang, ER Andrinopoulou, T Pestian, ... MethodsX 8, 101313, 2021 | 1 | 2021 |
| Body composition of patients with CF at the time of pulmonary exacerbation T Boat, E Hente, S Wang, J Taylor, S Summers, RD Szczesniak, E Gecilli, ... PEDIATRIC PULMONOLOGY 54, S254-S254, 2019 | 1 | 2019 |
| Characterizing socioeconomic deprivation, climate and high traffic pollution improves prediction of lung-function trajectories RD Szczesniak, C Brokamp, P Ryan, Y Ni, E Andrinopoulou, RH Keogh, ... PEDIATRIC PULMONOLOGY 54, S233-S234, 2019 | 1 | 2019 |
| Predicting lung function decline in cystic fibrosis: the impact of initiating ivacaftor therapy GC Zhou, Z Wang, AK Palipana, ER Andrinopoulou, P Miranda Afonso, ... Respiratory Research 25 (1), 1-9, 2024 | | 2024 |
| Social-environmental phenotypes of rapid cystic fibrosis lung disease progression in adolescents and young adults living in the United States AK Palipana, A Vancil, E Gecili, E Rasnick, D Ehrlich, T Pestian, ... Environmental advances 14, 100449, 2023 | | 2023 |
| Compositions and methods for the treatment of bronchiolitis obliterans A Ziady, K Myers, SM Davies, R Szczesniak, E Gecili, EJ Skala, ... US Patent App. 18/019,322, 2023 | | 2023 |
Rhonda SzczesniakAssociate Professor of Biostatistics, Cincinnati Children's HospitalVerified email at cchmc.org
